[Latest] Global Apheresis Equipment Market Size/Share Worth USD 13,169.1 Million by 2033 at a 12.2% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segm...
Haemonetics Corporation (HAE)
Last haemonetics corporation earnings: 2/4 06:00 am
Check Earnings Report
US:NYSE Investor Relations:
phx.corporate-ir.net/phoenix.zhtml?c=72118&p=irol-irhome
Company Research
Source: Latest
Market size & share revenue was valued at approximately USD 4,165.1 Million in 2023 and is expected to reach USD 4,673.2 Million in 2024 and is expected to reach around USD 13,169.1 Million by 2033, at a CAGR of 12.2% between 2024 and 2033. The key market players listed in the report with their sales, revenues and strategies are Terumo BCT Inc., Fresenius SE & Co. KGaA, Haemonetics Corporation, Asahi Kasei Medical Co. Ltd., Baxter International Inc., Kaneka Corporation, B. Braun Melsungen AG, Nikkiso Co. Ltd., Medica S.p.A., Miltenyi Biotec, Thermo Fisher Scientific Inc., Hemonetics Corporation, Cerus Corporation, MacoPharma, Gambro, and others. Austin, TX, USA, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “ Apheresis Equipment Market Size, Trends and Insights By Product Type (Plasmapheresis Equipment, Photopheresis Equipment, LDL Apheresis Equipment, Others), By Technology (Centrifugation Apheresis, Membrane Filtration Apheresi
Show less
Read more
Impact Snapshot
Event Time:
HAE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HAE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HAE alerts
High impacting Haemonetics Corporation news events
Weekly update
A roundup of the hottest topics
HAE
News
- HAE or SYK: Which Is the Better Value Stock Right Now? [Yahoo! Finance]Yahoo! Finance
- Are Investors Undervaluing Haemonetics (HAE) Right Now? [Yahoo! Finance]Yahoo! Finance
- Haemonetics Co. (NYSE: HAE) is now covered by analysts at JPMorgan Chase & Co.. They set an "overweight" rating and a $116.00 price target on the stock.MarketBeat
- Wall Street Analysts See a 27.84% Upside in Haemonetics (HAE): Can the Stock Really Move This High? [Yahoo! Finance]Yahoo! Finance
- Haemonetics Co. (NYSE: HAE) had its "outperform" rating re-affirmed by analysts at Barrington Research. They now have a $108.00 price target on the stock.MarketBeat
HAE
Earnings
- 11/8/24 - Beat
HAE
Sec Filings
- 12/3/24 - Form 8-K
- 11/14/24 - Form SC
- 11/12/24 - Form SC
- HAE's page on the SEC website